Compounds > sertraline
Page last updated: 2024-08-24

sertraline and Abnormalities, Drug-Induced

sertraline has been researched along with Abnormalities, Drug-Induced in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (37.50)18.2507
2000's2 (25.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bérard, A; Sheehy, O; Zhao, JP1
Freeman, MP1
Armbrust, KL; Black, MC; Conners, DE; Kwon, JW; Rogers, ED1
Antonioli, L; Blandizzi, C; Colucci, R; Corona, T; Fornai, M; Mantarro, S; Montagnani, S; Pergola, A; Ruggiero, E; Scollo, C; Testi, A; Tuccori, M1
Chaudron, LH1
Brochu, J; Cook, L; Feldkamp, M; Koren, G; Kulin, NA; Matsui, D; Ormond, K; Pastuszak, A; Rieder, M; Sage, SR; Schick-Boschetto, B; Spivey, G; Stein-Schechman, AK1
Lauder, JM; Sadler, TW; Shuey, DL1

Reviews

2 review(s) available for sertraline and Abnormalities, Drug-Induced

ArticleYear
Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
    Postgraduate medicine, 2010, Volume: 122, Issue:4

    Topics: Abnormalities, Drug-Induced; Cardiovascular Abnormalities; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Maternal-Fetal Exchange; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline; Teratogens

2010
Complex challenges in treating depression during pregnancy.
    The American journal of psychiatry, 2013, Volume: 170, Issue:1

    Topics: Abnormalities, Drug-Induced; Adult; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Psychotherapy; Recurrence; Risk Assessment; Sertraline

2013

Other Studies

6 other study(ies) available for sertraline and Abnormalities, Drug-Induced

ArticleYear
Sertraline use during pregnancy and the risk of major malformations.
    American journal of obstetrics and gynecology, 2015, Volume: 212, Issue:6

    Topics: Abnormalities, Drug-Induced; Adult; Antidepressive Agents; Cohort Studies; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Trimester, First; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline

2015
An imperfect literature and evidence-based medicine.
    The Journal of clinical psychiatry, 2009, Volume: 70, Issue:3

    Topics: Abnormalities, Drug-Induced; Aged, 80 and over; Antidepressive Agents, Second-Generation; Depression, Postpartum; Evidence-Based Medicine; Female; Humans; Nortriptyline; Paroxetine; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topic; Review Literature as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior

2009
Growth and development of tadpoles (Xenopus laevis) exposed to selective serotonin reuptake inhibitors, fluoxetine and sertraline, throughout metamorphosis.
    Environmental toxicology and chemistry, 2009, Volume: 28, Issue:12

    Topics: Abnormalities, Drug-Induced; Animals; Dose-Response Relationship, Drug; Fluoxetine; Larva; Metamorphosis, Biological; Selective Serotonin Reuptake Inhibitors; Sertraline; Water Pollutants, Chemical; Xenopus laevis

2009
Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.
    JAMA, 1998, Feb-25, Volume: 279, Issue:8

    Topics: 1-Naphthylamine; Abnormalities, Drug-Induced; Adult; Antidepressive Agents; Cohort Studies; Female; Fluvoxamine; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline

1998
Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
    Prescrire international, 1999, Volume: 8, Issue:43

    Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Child; Child, Preschool; Clinical Trials as Topic; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Infant; Infant, Newborn; Paroxetine; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1999
Serotonin as a regulator of craniofacial morphogenesis: site specific malformations following exposure to serotonin uptake inhibitors.
    Teratology, 1992, Volume: 46, Issue:4

    Topics: 1-Naphthylamine; Abnormalities, Drug-Induced; Amitriptyline; Animals; Cell Death; Cell Division; Epithelium; Facial Bones; Female; Fluoxetine; Mice; Mice, Inbred ICR; Morphogenesis; Pinocytosis; Pregnancy; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Skull; Yolk Sac

1992